Vaginal Mass — Assessment & Management

Safety

Red Flags — Genital Tract Malignancy, Torsion & Obstetric Emergency

Done

Vaginal or vulvar mass + irregular bleeding + contact bleeding or postcoital bleeding + postmenopausal bleeding + older woman Cervical, vaginal, or vulvar carcinoma. → gynaecology suspected cancer pathway referral. Colposcopy + biopsy urgent. Do not examine repeatedly without specialist involvement.

Rapidly enlarging pelvic mass + severe pain + peritonism + haemodynamic instability + collapse in a woman of reproductive age Ovarian torsion or ruptured ectopic pregnancy. → 999. IV access. Laparoscopy urgently. HCG in any reproductive-age woman.

Vaginal mass, bleeding or persistent discharge in a prepubertal child Possible rhabdomyosarcoma (sarcoma botryoides — grape-like polypoid vaginal mass in young girls) or sexual abuse. → urgent paediatric gynaecology assessment and safeguarding consideration, using the local suspected sarcoma/paediatric oncology pathway. Do not biopsy or excise in primary care.

Prolapsed mass at the introitus + haemorrhage + inability to reduce + vascular congestion or necrosis Incarcerated uterine prolapse or prolapsed submucous fibroid with torsion. → emergency referral. Do not attempt reduction of a necrotic, bleeding, severely painful or suspicious mass, and avoid repeated manipulation of an uncharacterised prolapsed mass. Selected uncomplicated prolapse: a single gentle attempt with analgesia and lubrication only if trained; urgent hospital assessment if reduction fails. Acute urinary retention with prolapse → same-day assessment and bladder decompression (catheterise), with urgent gynaecology or urology advice. Vaginal packing per local specialist advice.

Vaginal mass in pregnancy + antepartum haemorrhage + suspicious cervical friability on speculum examination Cervical carcinoma in pregnancy or placenta praevia. → same-day obstetric assessment (999 if heavy bleeding or unstable). Avoid digital vaginal examination until placenta praevia has been excluded; any speculum examination only where clinically indicated and within the appropriate obstetric pathway.

Vaginal swelling + fever + perineal pain + spreading erythema + crepitus Bartholin gland abscess or necrotising fasciitis of the vulva/vagina. → 999 (if necrotising). Same-day gynaecology for Bartholin abscess. See the vulvar disorders protocol.

New Bartholin mass in a woman aged 40 or over Possible Bartholin gland malignancy. → urgent gynaecological assessment and consideration of biopsy/excision to exclude malignancy.

Rhabdomyosarcoma of the vagina (sarcoma botryoides) is the most common malignant vaginal tumour in girls under 5 — it is a highly malignant soft-tissue sarcoma arising from the rhabdomyoblasts of the vaginal wall, presenting as a grape-like or polypoid mass protruding from the vaginal introitus, often associated with bloody vaginal discharge. The grape-like appearance ('botryoides' = Greek for grape) is pathognomonic. The median age at diagnosis is 2-3 years. Any vaginal mass or bleeding in a prepubertal girl is a paediatric emergency — it requires urgent paediatric gynaecology assessment through the local suspected sarcoma/paediatric oncology pathway (not a general gynaecology clinic) and simultaneous safeguarding assessment (to exclude sexual abuse as a concurrent concern, since both can present with genital abnormalities). A GP should never attempt biopsy or examination under anaesthesia for a suspected vaginal mass in a child — this must be performed at a specialist centre.

Diagnose

Classification of Vaginal Mass

Done

Vaginal wall masses

Bartholin gland cyst/abscess is vulval, not a true vaginal-wall mass: posterolateral vaginal opening, classically at 4 or 8 o'clock — see the vulvar disorders protocol; a new Bartholin mass at 40 or over needs urgent gynaecological assessment. Gartner duct cyst (embryological remnant of mesonephric duct): anterolateral vaginal wall, smooth, cystic, non-tender, often found incidentally — but do not label a vaginal-wall mass a Gartner cyst with confidence unless the features are clearly typical. Nabothian cyst (cervical): small smooth white cysts on cervix — mucous gland retention cysts, benign. Inclusion cyst (post-surgical): typically in posterior vaginal wall at episiotomy or laceration repair site — firm, non-tender. Vaginal wall fibroma, lipoma, or leiomyoma: rare benign mesenchymal tumours. VAIN (vaginal intraepithelial neoplasia): flat, white/red abnormal areas on vaginal wall — HPV-related, premalignant, detected on colposcopy.

Prolapsing structures — pelvic organ prolapse

Cystocele (anterior vaginal wall prolapse): bladder bulging into anterior vaginal wall — associated with urinary symptoms (stress incontinence, urgency, incomplete emptying). Rectocele (posterior vaginal wall prolapse): rectum bulging into posterior vaginal wall — associated with difficulty defaecating, digitation required to facilitate defaecation. Uterine prolapse: descent of the uterus into the vaginal canal — simplified clinical (Baden–Walker-style) degrees, not POP-Q: I (cervix within vagina), II (cervix at introitus), III (cervix outside introitus), IV/procidentia (complete eversion of uterus). Vault prolapse (post-hysterectomy): vaginal apex descends — may contain bladder (cystocele) or bowel (enterocele) or rectum. Enterocele: small bowel herniating into upper posterior vaginal wall.

Cervical and uterine causes

Cervical polyp: usually benign, red, smooth, pedunculated from cervical canal (occasionally endometrial in origin) — most common cause of intermenstrual/postcoital bleeding in premenopausal women. Submucous fibroid protruding through the cervix: irregular, hard, pedunculated leiomyoma. Cervical carcinoma: irregular, friable, bleeding on contact — suspected cancer pathway referral. Uterine sarcoma (rare): large, rapidly growing, irregular uterine mass.

Cystocele (anterior vaginal wall prolapse) is the most common type of pelvic organ prolapse and is frequently under-diagnosed in primary care — it presents as a bulge felt at the vaginal entrance, worse on straining or standing and relieved by lying down. The associated urinary symptoms are clinically important: stress urinary incontinence (the bladder angle is disturbed), urgency and frequency (bladder descent distorts the urethra), difficulty fully emptying the bladder (bladder kinking), and paradoxically — prolapse can sometimes improve stress incontinence by kinking the urethra (creating pseudo-continence that is unmasked after surgical repair). In primary care, document the compartment involved, the leading edge relative to the hymen, symptoms and whether the prolapse is reducible. Formal POP-Q staging (measured points Aa, Ba, C, D, Ap, Bp and TVL relative to the hymen) should be performed in the specialist prolapse service where required — do not label simplified stage I–IV descriptions as POP-Q. Management is guided by symptoms, quality of life and patient preference, not stage alone (NICE NG123).

Diagnose

Assessment — History, Examination & Investigations

Done

History

Presenting complaint: vaginal bulge or lump (prolapse), vaginal discharge or bleeding (polyp, malignancy, infection), dyspareunia (cyst, prolapse, malignancy), urinary symptoms (cystocele, UTI, malignancy). Prolapse symptoms: pelvic heaviness, dragging sensation, sensation of something falling out, worsened by standing/straining/activity, relieved by lying down. Bleeding: intermenstrual (cervical polyp, endometrial), postcoital (cervical polyp, cervicitis, cervical carcinoma), postmenopausal bleeding (a symptom requiring urgent assessment, not a diagnosis: any unexplained postmenopausal bleeding requires assessment through the local suspected-cancer pathway — follow NG12: referral at 55 and over if not attributable to HRT; consider referral under 55). New unexplained vaginal discharge at 55 or over: check the current NG12 direct-access ultrasound criterion; do not label post-menopausal discharge as BV, atrophy or prolapse without assessment. Bowel symptoms: difficulty defaecating, digitation (rectocele). Obstetric history: number of deliveries, instrumental delivery (forceps — a risk factor for levator ani injury), large babies, perineal tears. Menstrual: age at menopause, HRT use. PMH: previous pelvic surgery (vault prolapse risk), pelvic radiotherapy (VAIN, fistula), cervical smear history.

Examination

Inspect the vulva and introitus. Speculum examination where appropriate and consented; visualise the cervix if bleeding or discharge is present. Do not perform digital vaginal examination in suspected placenta praevia before obstetric assessment. Assess prolapse with coughing/straining and document the compartment and leading edge relative to the hymen; assess urinary, bowel and sexual symptoms. (Cusco bivalve speculum for cervical visualisation; Sim's speculum for prolapse assessment — patient in left lateral or standing for prolapse). Cervix: assess for polyps, ectopy (physiological — columnar epithelium visible, common in young women), contact bleeding, irregular friable areas (carcinoma), nabothian cysts. Anterior wall: cystocele assessment (ask patient to strain — anterior wall bulge). Posterior wall: rectocele (posterior wall bulge). Uterine descent: ask patient to strain maximally + cough. Vaginal wall: any masses, lesions, VAIN changes (white/red lesions — colposcopy if suspected). Levator ani assessment (digital PV — muscle weakness/avulsion).

Investigations

Targeted swabs only — not routine for every vaginal mass or prolapse: vaginal swab if discharge or infection is suspected or the diagnosis is uncertain; STI NAAT according to sexual history and symptoms; urine testing if urinary symptoms · Cervical smear/HPV test (routine screening only if due — cervical screening is not a diagnostic test for symptomatic or suspicious cervical disease; do NOT perform it from a suspicious or actively bleeding cervix — suspected cancer pathway referral for colposcopy/biopsy instead) · Pregnancy test (urine HCG) (where relevant, including any reproductive-age woman with a pelvic mass) · Pelvic USS (transvaginal) (suspected uterine/adnexal pathology, an unclear internal mass or uncertain anatomy; no routine imaging for clinically evident uncomplicated prolapse) · Urodynamics — not in primary care (do not request routinely because prolapse is present; refer for specialist assessment where symptoms are complex, diagnosis is uncertain, voiding dysfunction is present, or urodynamic testing may alter surgical planning) · MRI pelvis (suspected malignancy staging, complex fistula) · CA-125 (only through an ovarian-cancer pathway: if ovarian cancer is suspected from persistent abdominal, pelvic or urinary symptoms, bloating, early satiety or an adnexal/pelvic mass, follow NG12 and arrange CA125 and pelvic ultrasound as indicated; do not order CA125 solely because a vaginal mass is present — RMI is a specialist tool)

The postcoital bleeding assessment is one of the most important GP consultations for early cervical cancer detection — cervical cancer most commonly presents with postcoital bleeding (bleeding after sexual intercourse) because the cancer is at the transformation zone (squamocolumnar junction) and is highly vascular and friable. The GP's role: any woman with postcoital bleeding should have a speculum examination — the cervix must be directly visualised. If the cervix appears normal (smooth, no friable areas, no irregular lesion), the most likely diagnosis is cervical ectopy (columnar epithelium visible on ectocervix — physiological in young women on OCP or in pregnancy), and the management is reassurance or cryotherapy — but if bleeding persists with a normal cervix, follow the local abnormal bleeding/colposcopy or gynaecology pathway. If the cervix has any irregular, friable, bleeding, or ulcerated area: suspected cancer pathway referral for colposcopy regardless of cervical smear history or HPV status (cervical smears can be falsely negative in invasive carcinoma).

Diagnose

Prolapse Assessment, Cervical Polyp & Vaginal Cysts

Done

Pelvic organ prolapse — primary-care description

Document the compartment involved, the leading edge relative to the hymen, symptoms and whether the prolapse is reducible. The simplified stages below are not formal POP-Q staging, which is performed in the specialist prolapse service where required.

Simplified clinical stages

Stage I: prolapse descends more than 1 cm above the level of the hymen. Stage II: prolapse descends to within 1 cm of the hymen (at or just above introitus). Stage III: prolapse extends more than 1 cm below the hymen. Stage IV / Procidentia: complete eversion. Symptoms rarely correlate exactly with stage — some women with stage III prolapse are asymptomatic; some with stage I have significant symptoms. Quality of life questionnaire (PFDI-20 — Pelvic Floor Distress Inventory) is more useful than stage alone for guiding treatment decisions. Examination tip: prolapse is best assessed with patient straining/coughing — the extent can be significantly underestimated in the lithotomy position at rest.

Cervical polyp management

Most cervical polyps are benign (smooth, red, teardrop-shaped, from endocervical canal), but some arise from the endometrium. Do not remove a cervical polyp in primary care unless the clinician is specifically trained, the lesion is clearly benign, the local pathway supports the procedure and there are no suspicious symptoms or examination findings (not with postcoital or intermenstrual bleeding, a friable or suspicious cervix, possible pregnancy or diagnostic uncertainty). Send all removed tissue for histology. Refer lesions that are large, broad-based, recurrent, atypical, associated with unexplained bleeding or not clearly arising from the cervix. Do not use silver nitrate or Monsel's solution without a locally approved procedure and haemorrhage protocol. Recurrence: cervical polyps can recur — inform patient.

Vaginal cysts — Gartner vs Bartholin

Gartner duct cyst: anterolateral vaginal wall (2 and 10 o'clock positions), embryological remnant of Wolffian (mesonephric) duct, typically discovered incidentally on examination, thin-walled, non-tender, 1-3 cm. Management: a small, typical, asymptomatic vaginal-wall cyst may be observed if the diagnosis is clinically clear. Refer for gynaecological assessment or imaging if the lesion is atypical, large or deep, painful, enlarging or complex, bleeding, associated with urinary symptoms, in a child or young person, or diagnostically uncertain. Bartholin cyst (vulval, posterolateral, 4 and 8 o'clock): see the vulvar disorders protocol — a new Bartholin mass at 40 or over needs urgent gynaecological assessment. Skene duct cyst (periurethral): near the urethral meatus, small, usually asymptomatic.

The Gartner duct cyst is a clinical finding that often causes unnecessary patient anxiety when discovered unexpectedly on speculum examination — it is a benign embryological remnant of the mesonephric (Wolffian) duct that persists in some women as a cystic structure in the anterolateral vaginal wall. Typical features are smooth, thin-walled, small, non-tender and transilluminating, but a vaginal-wall mass should not automatically be labelled a Gartner cyst in primary care. It may be associated with ipsilateral renal anomalies (embryological — the mesonephric duct also gives rise to the ureteric bud). Management: a small, typical, asymptomatic cyst may be observed if the diagnosis is clinically clear; refer for gynaecological assessment or imaging if the lesion is atypical, symptomatic, enlarging or diagnostically uncertain (aspiration or marsupialisation may be offered for symptomatic cysts). Documenting the examination finding accurately (site, size, consistency, symptoms and the plan) supports safe review.

Refer

Referral Pathways

Done

999

Irreducible necrotic uterine prolapse (inability to reduce + vascular compromise) · Haemodynamic instability or suspected ruptured ectopic (NICE NG126) · Necrotising infection of vagina/vulva

Suspected cancer: gynaecology

Postmenopausal vaginal bleeding at 55 and over, not attributable to HRT (consider under 55) — follow NG12 exactly · New unexplained vaginal discharge at 55 or over → check the current NG12 direct-access ultrasound criterion · Suspicious cervix (irregular, friable or bleeding) · Suspicious vaginal lesion or vaginal mass · Suspected VAIN (abnormal vaginal wall lesion)

Paediatric gynaecology + safeguarding

Any vaginal mass, bleeding or persistent discharge in a prepubertal child → urgent assessment via the local suspected sarcoma/paediatric oncology pathway; do not biopsy or excise in primary care

Gynaecology (urgent)

New Bartholin mass at 40 or over (urgent) · Bartholin abscess (same-day) · Cervical polyp that is large, broad-based, recurrent, atypical, associated with unexplained bleeding or not clearly cervical (outpatient polypectomy) · Atypical, symptomatic, enlarging or uncertain vaginal-wall cyst · Prolapsed submucous fibroid (menorrhagia + prolapsing mass) · Vault prolapse symptomatic (RCOG/BSUG Green-top Guideline No. 46)

Urogynaecology / pelvic floor physiotherapy

Refer symptomatic prolapse affecting quality of life, prolapse associated with significant urinary or bowel dysfunction (e.g. digitation required), diagnostic uncertainty, complications, failed conservative treatment, or where the patient wishes to discuss pessary or surgery — not stage alone. Asymptomatic prolapse can generally be managed conservatively with advice and review.

GP management

Asymptomatic prolapse: reassurance, advice and safety-net; lifestyle (weight loss if BMI over 30, constipation treatment, stop smoking, minimise heavy lifting). Symptomatic stage 1–2: supervised pelvic-floor muscle training for at least 16 weeks. Nabothian cysts: benign, reassure. Cervical ectopy: reassure if asymptomatic; cryotherapy or silver nitrate if symptomatic contact bleeding (GP procedure or colposcopy clinic). Small, typical, asymptomatic vaginal-wall cyst: observe if the diagnosis is clinically clear.

The postmenopausal bleeding (PMB) pathway warrants a very low threshold — NICE NG12 (updated April 2026) recommends a suspected cancer pathway referral for unexplained PMB not attributable to HRT at age 55 and over, and advises considering it under 55 (postmenopausal = no periods for 12 months). The exceptions are narrow: if a woman is on sequential HRT (known cyclical withdrawal bleeding) or combined HRT with documented regular spotting that has not changed — but even here, any change in bleeding pattern, unusual timing, or new onset of postmenopausal bleeding requires assessment against the same NG12 criteria (referral at 55 and over; consider under 55). The endometrial cancer risk is higher in women with BMI >30, diabetes, nulliparity or tamoxifen use. Investigation pathway: transvaginal ultrasound (endometrial thickness ≤4 mm = very low risk; >4 mm = pipelle endometrial biopsy). NG12 recommends referral at 55 and over and advises considering it under 55, so managing PMB without referral, even after a single episode, needs a clear clinical reason that is documented; under 55, record the decision and the reason whichever way it goes.

Treat

Pelvic Organ Prolapse — Conservative & Surgical Management

Done

Conservative managementAsymptomatic prolapse: reassurance, advice and safety-net. Symptomatic: consider supervised pelvic-floor muscle training through pelvic health physiotherapy for at least 16 weeks in symptomatic stage 1 or stage 2 prolapse (NICE NG123, 2019). Address constipation, chronic cough, smoking, obesity (discuss weight loss where BMI is over 30) and heavy lifting where relevant. Do not promise a specific reduction in stage or symptom score.

Vaginal pessary — symptomatic prolapse at any stage, alone or with PFMTRing pessary (most common): silicone ring inserted to support the bladder neck and anterior vaginal wall. Sizing: 60-100 mm (most women take 65-75 mm). Technique: fold into half-moon shape, insert, ensure comfortable positioning (patient should not feel it). Pessary fitting and ongoing care follow the local pessary/urogynaecology pathway: ensure the pessary is removed and the vagina inspected at least every 6 months, or more frequently if clinically indicated (NICE NG123); only trained and commissioned clinicians should remove and refit. Patients who self-manage need clear instructions and access to review for bleeding, pain, discharge, retention or expulsion. Consider low-dose vaginal oestrogen for pessary-related mucosal problems in postmenopausal women (per local formulary). Complications: vaginal discharge, pessary expulsion, vaginal erosion (remove the pessary until healed, vaginal oestrogen, refit a smaller size; gynaecology review if it does not heal). Cube pessary: for severe prolapse or vault prolapse where ring fails.

Surgical treatment — symptoms persist despite, or patient declines, non-surgical treatmentAnterior repair (colporrhaphy): for cystocele. Posterior repair: for rectocele. Sacrocolpopexy (laparoscopic or robotic): gold-standard for vault prolapse — mesh fixation to sacrum. Vaginal hysterectomy + pelvic floor repair: for uterine prolapse. Native tissue repair: preferred over mesh (NICE HTG456 (formerly IPG599, 2017): transvaginal mesh repair of anterior or posterior vaginal wall prolapse only in the context of research; NHS England paused transvaginal mesh in 2018). Manchester repair (conservative uterine surgery). Pelvic floor physiotherapy pre- and post-surgical.

The vaginal mesh controversy has significantly shaped UK pelvic floor surgery since 2018 — the Independent Medicines and Medical Devices Safety Review (Cumberlege Review, 2020) documented significant harm from vaginal mesh complications including chronic pelvic pain, mesh erosion through the vaginal wall, nerve damage, and dyspareunia in tens of thousands of women who had transvaginal mesh procedures for prolapse and stress incontinence. NHS England suspended transvaginal mesh procedures in 2018 pending safety regulation. Key developments: (1) sacrocolpopexy (abdominal/laparoscopic approach) mesh remains available as the standard for apical vault prolapse — this is anatomically and safety-profile distinct from transvaginal mesh; (2) mid-urethral sling (TVT/TOT) for stress urinary incontinence: under a national high-vigilance restriction (pause) since July 2018 — currently restricted to specialist mesh centres; (3) any woman with symptoms she believes are related to previous mesh implant should be referred to an NHS Mesh Complication Centre (meshcentres.nhs.uk). GPs must be aware of this issue and not dismiss mesh-related symptoms.

Treat

Vaginal Oestrogen, Cervical Ectopy & Discharge Management

Done

Vaginal oestrogen for prolapse-related symptoms

Postmenopausal atrophy worsens prolapse symptoms and pessary-related complications. Consider low-dose vaginal oestrogen in post-menopausal women with genitourinary symptoms, vaginal atrophy or pessary-related mucosal problems (NICE NG123). Use the lowest effective dose and follow current menopause and breast-cancer guidance; choose the product and regimen from the current local formulary and menopause pathway. Women with current or previous hormone-sensitive breast cancer need an individualised discussion — seek specialist (breast cancer/oncology) advice.

Cervical ectopy (erosion) management

Cervical ectopy (columnar epithelium visible on ectocervix): physiological, more common in young women and OCP users. Symptomatic ectopy causing excessive discharge or contact bleeding: cryotherapy or silver nitrate application, per the local procedure. Perform only if: cervical smear up to date and normal, no signs of infection (swabs clear), no suspicion of malignancy. Post-treatment: a watery discharge is expected; give the local aftercare advice. Refer: if recurrent symptoms, large ectopy, or doubt about diagnosis.

Vaginal discharge in the context of vaginal mass

Do not label post-menopausal discharge as BV, atrophy or prolapse without assessment; new unexplained discharge at 55 or over → check the NG12 direct-access ultrasound criterion. Offensive discharge + vaginal mass: consider: RPOC (retained products of conception — postpartum/miscarriage), submucous fibroid infection, pyometra (infected uterus — common in elderly postmenopausal women with cervical stenosis), vaginal foreign body (especially in children or elderly). Pyometra: transvaginal USS + urgent gynaecology. Vaginal foreign body in elderly: USS + gynaecology for removal under anaesthesia if needed. Child with vaginal discharge: safeguarding assessment + gynaecology.

Next steps: see Pelvic organ prolapse · Female urinary incontinence

The pyometra (pus-filled uterus) is a diagnosis that GPs must consider in postmenopausal women presenting with unusual vaginal discharge, pelvic pain, or fever — it occurs when cervical stenosis (from cervical cancer, radiotherapy, previous instrumentation, or atrophic postmenopausal changes) prevents drainage of uterine secretions, which then become infected. It can also be the presenting feature of endometrial carcinoma obstructing the cervical canal. Clinical features: elderly postmenopausal woman with offensive vaginal discharge (or no discharge if completely obstructed), lower abdominal pain, fever, and a tender enlarged uterus on bimanual examination. Transvaginal ultrasound shows a fluid-filled uterine cavity. Management: urgent gynaecology referral — cervical dilation for drainage + endometrial sampling (to exclude carcinoma) + IV antibiotics. A substantial proportion of pyometra cases have an underlying gynaecological malignancy, so endometrial sampling is essential.

Lifestyle

Pelvic Floor Health, Prevention & Prolapse Self-Care

Done

Pelvic floor exercises — correct technique Contract the pelvic floor muscles (the muscles used to stop urine mid-flow — but do not actually stop urine mid-flow as a test, as this can cause bladder dysfunction). Three components: (1) slow holds (squeeze and lift, hold for 10 seconds, 10 repetitions, 3x daily); (2) quick flicks (fast on-off contractions, 10 repetitions); (3) functional contractions (contract before coughing, sneezing, lifting — "the knack"). Pelvic Health Physio (NHS Squeezy App): guided, reminder-based, validated. Most women do pelvic floor exercises incorrectly — physiotherapy assessment essential.

Weight management for prolapse Obesity is a risk factor for prolapse symptoms. Discuss weight loss where BMI is over 30 (NICE NG123), using the NICE NG246 weight management pathway.

Constipation avoidance Chronic straining at defaecation is a modifiable risk factor — prevent and treat constipation (NICE NG123). Management: dietary fibre (25-30g/day), adequate hydration (1.5-2L/day), regular physical activity. Laxatives for chronic constipation: macrogol (Movicol) first-line. Correct defaecation posture: squatting position (step stool to raise feet — Squatty Potty concept) straightens the anorectal angle and reduces straining effort.

Pregnancy, childbirth and pelvic floor protection Levator ani muscle injury during vaginal delivery is an important risk factor for pelvic organ prolapse — instrumental delivery (especially forceps), prolonged second stage, large birthweight, and episiotomy are all risk factors. Antenatal pelvic floor exercises: may reduce but do not eliminate pelvic floor damage. Early referral to pelvic floor physiotherapy after 3rd/4th degree perineal tears. Postnatal pelvic floor exercises: from day 1 postpartum. 6-week postnatal check: screen for urinary incontinence and prolapse symptoms.

Occupational factors and prolapse Heavy lifting is associated with worsened prolapse symptoms (not necessarily increased incidence in most studies) — manual workers should be given occupational guidance: lift with knees not back, exhale during effort, contract pelvic floor before lifting. Occupational health referral for women with symptomatic prolapse in physically demanding occupations. Individualise work advice and fit notes for women awaiting treatment, based on symptoms and job demands.

Sexual wellbeing and prolapse Symptomatic prolapse can affect sexual function and self-image — ask about sexual symptoms. Acknowledge at every consultation. Ring pessary: can remain in situ during intercourse (reassure patient). After surgical repair: abstain from intercourse for 6-8 weeks. Psychosexual therapy: for persistent sexual dysfunction after surgical repair. RELATE (relate.org.uk) for relationship support.

Vaginal dryness and GSM co-management with prolapse Genitourinary syndrome of menopause (GSM) frequently co-occurs with pelvic organ prolapse in postmenopausal women — vaginal atrophy worsens prolapse symptoms (dry, fragile mucosa reduces the self-lubrication that supports comfortable prolapse management with a pessary) and causes its own symptoms (dyspareunia, urinary urgency, recurrent UTIs). Consider low-dose vaginal oestrogen for menopausal genitourinary symptoms (NICE NG123), from the local formulary, with specialist advice where there is a history of hormone-sensitive breast cancer.

Prolapse support organisations Pelvic Obstetric and Gynaecological Physiotherapy (POGP — pogp.csp.org.uk): directory of specialist pelvic health physiotherapists. Pelvic Floor First (Australia): excellent evidence-based patient resources, used by NHS pelvic floor services. NHS Meshcentres (meshcentres.nhs.uk): for women with symptoms attributed to previous mesh. Continence Product Advisor (continenceproductadvisor.org): guide to continence products available on NHS prescription.

NICE NG123 (2019) on pelvic organ prolapse advises considering a programme of pelvic floor muscle training supervised by a physiotherapist for at least 16 weeks as a first option for symptomatic POP-Q stage 1 or 2 prolapse; women with more advanced prolapse can still benefit alongside a pessary or while awaiting surgery. Supervised PFMT can improve prolapse symptoms and quality of life, but do not promise a specific reduction in stage or symptom score. Consider supervised PFMT through pelvic health physiotherapy for symptomatic stage 1–2 prolapse; a pessary can be considered for symptomatic prolapse at any stage, alone or with physiotherapy; asymptomatic prolapse can generally be managed with advice and review. NHS pelvic health physiotherapy services are available in all areas (waiting times vary from weeks to months).

Safety

Follow-Up, Pessary Management & Safety-Netting

Done

Prolapse monitoring

Pelvic floor physiotherapy: review at 16 weeks (symptom score, examination, stage assessment). If PFMT + pessary not achieving adequate control: gynaecology or urogynaecology referral. Review if managed conservatively: symptom score and any new symptoms; pessary removed and inspected at least every 6 months (local pathway).

Pessary management in GP

Pessary fitting and ongoing care follow the local pessary/urogynaecology pathway. Ensure the pessary is removed and the vagina inspected at least every 6 months, or more frequently if clinically indicated (pessary type, erosion, bleeding or discharge, inability to self-manage, cognitive or physical impairment). Only practices trained and commissioned to do so should remove and refit. Self-managing patients: clear instructions and access to review for bleeding, pain, discharge, retention or expulsion. Document size + date. Consider low-dose vaginal oestrogen in postmenopausal pessary users (local formulary). If unable to retain ring pessary: shelf pessary or cube pessary (gynaecology-fitted). If vaginal erosion (pain + bleeding + erosion visible on speculum): remove pessary until healed (2-4 weeks), treat with local oestrogen, refit smaller size; gynaecology review if it does not heal.

Postcoital or intermenstrual bleeding

Postcoital, intermenstrual or persistent abnormal bleeding requires history, pregnancy testing where relevant, speculum examination and appropriate STI testing. Cervical screening is not a diagnostic test for symptomatic or suspicious cervical disease. If the cervix is normal but bleeding persists, follow the local abnormal bleeding/colposcopy or gynaecology pathway — no age threshold applies. If postmenopausal, follow the NG12 postmenopausal bleeding route below (suspected cancer pathway referral at 55 and over; consider under 55). If the cervix looks suspicious of cancer, NG12 advises considering a suspected cancer pathway referral. Cervical ectopy causing symptomatic bleeding: cryotherapy or colposcopy clinic referral.

Postmenopausal bleeding

A symptom requiring urgent assessment, not a diagnosis: any unexplained postmenopausal bleeding requires assessment through the local suspected-cancer pathway. NICE NG12 (updated April 2026): unexplained postmenopausal bleeding not attributable to HRT → suspected cancer pathway referral at age 55 and over; consider the same referral under 55. Keep a low threshold, and document referral and outcome.

999

Incarcerated prolapse + vascular compromise · Ruptured ectopic · Necrotising fasciitis

Suspected cancer

Postmenopausal bleeding at 55 and over, not attributable to HRT (consider under 55) · Irregular/friable/bleeding cervix · Abnormal vaginal wall lesion (VAIN concern) or suspicious vaginal mass · New Bartholin mass at 40 or over (urgent gynaecology) · Any vaginal mass, bleeding or persistent discharge in a prepubertal child (urgent paediatric gynaecology + safeguarding)

Pessary care follows the local pessary/urogynaecology pathway, and not every practice is trained or commissioned to remove and refit pessaries. Where a clinician is trained and commissioned, the steps are to: (1) remove a ring pessary (insert fingers into vagina, locate the posterior rim, hook one finger under it and pull forward + down); (2) inspect the vaginal mucosa for any erosion (red raw area) or discharge; (3) clean the pessary with mild soap and water; (4) assess whether it needs upsizing or downsizing (if easily expelled = upsize; if causing discomfort = downsize); and (5) reinsert (fold into half-moon, insert, confirm in correct position — patient should not feel it). GPs without this training should refer patients for hospital or community gynaecology nurse pessary clinics — leaving a ring pessary in situ without checking for more than 6 months risks undetected erosion.